Man Group
RYTM icon

Man Group’s Rhythm Pharmaceuticals RYTM Stock Holding History

Man Group’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$350K Sell
4,022
-5,536
-58% -$538K ﹤0.01% 2179
2025
Q4 		$1.02M Sell
9,558
-119,772
-93% -$12.7M ﹤0.01% 1668
2025
Q3 		$13.1M Buy
+129,330
New +$12M 0.02% 681
2023
Q3 		– Hold
0
– – – 1693
2018
Q4 		– Sell
-56,360
Closed -$1.64M – 2088
2018
Q3 		$1.64M Buy
+56,360
New +$1.78M 0.01% 1490

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Man Group's RYTM Position: Q1 2026 in Review

Man Group reduced its Rhythm Pharmaceuticals (RYTM) stake by 58% in Q1 2026, selling an estimated $538K and leaving 4,022 shares worth $350K. The position accounts for ﹤0.01% of the portfolio, ranked #2179.

Man Group first reported a position in RYTM in Q3 2018 and has held it in 4 quarters since. The position peaked at $13.1M in Q3 2025. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Man Group held 4,022 shares of Rhythm Pharmaceuticals worth $350K as of Q1 2026.
  • Man Group sold 5,536 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $538K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Man Group's portfolio in Q1 2026, its #2179 holding.
  • Man Group first reported a position in Rhythm Pharmaceuticals in Q3 2018 and has held it in 4 quarters since.
  • Man Group's Rhythm Pharmaceuticals position peaked at $13.1M in Q3 2025.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.